Webinars and Videos
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
RISW Conference 2026
Berry Consultants is excited to share a short video highlighting members of our team and their planned presentations at the upcoming ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop (RISW) in Rockville, Maryland, September 16-18, 2026.
77: NFL Study of CTE: The Issues
In this episode of "In the Interim…", Dr. Scott Berry examines three recent health-research headlines through a statistician's lens: an Adventist Health Study-2 analysis, an Emory University trial, and a British Medical Journal study.
76: Talkin' 'bout Sweet Time
In this episode of "In the Interim...", Dr. Scott Berry dissects prevailing concepts of “clinically meaningful difference” in clinical trials focusing on progressive diseases.
Simulation Guided Trial Design: Designing a Phase 3 Group Sequential Trial
Designing a group sequential phase 3 with a long time to final endpoint, using longitudinal modelling and Bayesian predictive probabilities for decision making at the interims.
Simulation Guided Trial Design: Designing a Seamless Phase 2/3 Trial
Designing a trial with three arms compared to placebo and Active Comparator, using two endpoints: an early endpoint to compare to PBO for futility & arm selection in phase 2, and a late efficacy endpoint to compare against the AC.
Simulation Guided Trial Design: A Phase 2 Platform Screening Trial
Designing a platform trial to test several assets in the same indication that will become available over time.
No results found.
There are no results with this criteria. Try changing your search.